Russian Senator Calls for Citizen Smoking Law Enforcement Mobile App

Regulations by 2FIRSTS.ai
May.21.2024
Russian Senator Calls for Citizen Smoking Law Enforcement Mobile App
Russian Senator Airat Gibatdinov has proposed a tobacco-reporting app to crack down on illegal sales and protect consumers' rights.

According to a report by Fedpress on May 21, Russian Senator Airat Gibatdinov has called for an anti-tobacco proposal, allowing Russians to report any illegal activities in the field of tobacco.

 

The senator proposed launching a mobile application called "Citizen Prosecutor" that would allow every citizen to easily report violations of cigarette and e-cigarette sales regulations.

 

Starting from April 1, 2024, Russia has increased penalties for unauthorized tobacco sales and has banned the public display of tobacco products. However, some merchants are still violating these regulations by setting up their sales points in busy areas and prominently displaying their products.

 

The senator expressed regret that the Russian Federal Supervisory Agency for Consumer Rights Protection does not have enough resources to conduct regular inspections of all sales points. He believes that the application will be similar to a "civilian prosecutor" application for recording traffic violations. In addition, the senator also mentioned the issue of openly selling open system products, pointing out that they are particularly attractive to teenagers. Although there are restrictions on the sale of these goods, they can still be freely displayed at stalls, including those in high-traffic shopping centers.

 

Members of the Senate believe that it is necessary to stop all of these behaviors in the field by implementing strict regulatory mechanisms.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Polish Vape Industry Write to PM: End Excessive Inspections, Communicate, Respect Rule of Law
Polish Vape Industry Write to PM: End Excessive Inspections, Communicate, Respect Rule of Law
Polish e-cigarette firms urge the Prime Minister to stop excessive enforcement, start industry dialogue, and ensure fair, proportionate regulation. They warn current measures risk market instability and gray market growth.
Apr.29 by 2FIRSTS.ai
[2Firsts Special Report] EPO Enlarged Board of Appeal Issues Key Decision: China YTI Gains Procedural Advantage in Heated Tobacco Patent Dispute with Philip Morris
[2Firsts Special Report] EPO Enlarged Board of Appeal Issues Key Decision: China YTI Gains Procedural Advantage in Heated Tobacco Patent Dispute with Philip Morris
The EPO’s Enlarged Board of Appeal has issued decision G 1/24, confirming that claims must always be interpreted with reference to the description and drawings. This standard supports the position of China YTI in its heated tobacco patent dispute with Philip Morris, giving the Chinese company a procedural advantage. The case now returns to the Technical Board of Appeal for further review.
Jun.19
South Korea Report: Heated Tobacco Sales Soar 2,500-Fold Globally Over a Decade, Prompting Urgent Call for Stricter Regulations
South Korea Report: Heated Tobacco Sales Soar 2,500-Fold Globally Over a Decade, Prompting Urgent Call for Stricter Regulations
The Korea Health Promotion Institute has called for stronger regulation of e-cigarettes and other novel tobacco products, emphasizing the need to protect minors from the influence of tobacco advertising.
May.21 by 2FIRSTS.ai
OXVA Launches Xlim SQ Pro 2 with 1.09-Inch Touchscreen and Six Built-In Tools
OXVA Launches Xlim SQ Pro 2 with 1.09-Inch Touchscreen and Six Built-In Tools
OXVA has introduced the Xlim SQ Pro 2, an open-system vaping device featuring a 1600mAh battery and a 1.09-inch HD touchscreen. The device is compatible with the full range of XLIM PODS cartridges and includes six built-in tools, such as a flashlight and stopwatch. The Xlim SQ Pro 2 is now available for online purchase in markets including the United Kingdom, Saudi Arabia, and Egypt.
May.09 by 2FIRSTS.ai
$1.5 Million in Smuggled Tobacco Seized by Philippine Customs
$1.5 Million in Smuggled Tobacco Seized by Philippine Customs
The Philippine Bureau of Customs seized $1.5 million worth of smuggled cigarettes in Bulacan Province, involving multiple brands. The operation was praised by Philip Morris International and Japan Tobacco International.
Apr.28 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai